No abstract available
MeSH terms
-
COVID-19 Vaccines / adverse effects
-
COVID-19* / prevention & control
-
Humans
-
Neuroendocrine Tumors*
-
Octreotide / therapeutic use
-
Organometallic Compounds* / therapeutic use
-
Positron-Emission Tomography
-
Radionuclide Imaging
-
Vaccination
Substances
-
COVID-19 Vaccines
-
Organometallic Compounds
-
copper dotatate CU-64
-
Octreotide